Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuyue Ren

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2017
Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma PatientsYuyue Ren, Xiaoyun Li, Wei Wang, et al.
Frontiers in Immunology|November 7, 2025
Innate immunity in tumors: roles and therapeutic targetsSongze Leng, Yuyue Ren, Yaoyao Tian, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 17, 2018
Orai1 and Stim1 Mediate the Majority of Store-Operated Calcium Entry in Multiple Myeloma and Have Strong Implications for Adverse PrognosisWei Wang, Yuyue Ren, Lianjie Wang, et al.
Acta Haematologica|January 22, 2020
Coexistence of Pure Red Cell Aplasia and Autoimmune Haemolytic Anaemia Associated with ThymomaWei Wang, Li-Yan Chen, Weiwei Zhao, et al.
BMC Cancer|July 5, 2023
Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patientsYuyue Ren, Yijun Liu, Wanting He, et al.
Cell Cycle (Georgetown, Tex.)|April 29, 2016
Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosisYuyue Ren, Yunhe Gu, Wei Wang, et al.
Cancer Gene Therapy|October 24, 2025
Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic valueYuyue Ren, Ming Liu, Jiancheng Fang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2017
Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma PatientsYuyue Ren, Xiaoyun Li, Wei Wang, et al.
Frontiers in Immunology|November 7, 2025
Innate immunity in tumors: roles and therapeutic targetsSongze Leng, Yuyue Ren, Yaoyao Tian, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 17, 2018
Orai1 and Stim1 Mediate the Majority of Store-Operated Calcium Entry in Multiple Myeloma and Have Strong Implications for Adverse PrognosisWei Wang, Yuyue Ren, Lianjie Wang, et al.
Acta Haematologica|January 22, 2020
Coexistence of Pure Red Cell Aplasia and Autoimmune Haemolytic Anaemia Associated with ThymomaWei Wang, Li-Yan Chen, Weiwei Zhao, et al.
BMC Cancer|July 5, 2023
Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patientsYuyue Ren, Yijun Liu, Wanting He, et al.
Cell Cycle (Georgetown, Tex.)|April 29, 2016
Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosisYuyue Ren, Yunhe Gu, Wei Wang, et al.
Cancer Gene Therapy|October 24, 2025
Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic valueYuyue Ren, Ming Liu, Jiancheng Fang, et al.
Pageof 1